Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist. Feladilimab binds to ICOS-expressing T cells, induces IFNgamma, and increases PD-1/L1 expression. Feladilimab has anti-tumor activity and can be used to study cancer.
CAS Number:
[2252518-85-5]
Target:
GSK3359609
* VAT and and shipping costs not included. Errors and price changes excepted